Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast parameters
1.4 COVID-19 impact at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Influenza diagnostic tests industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Test type trend
2.5 End-use trends
Chapter 3 Influenza Diagnostic Tests Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of influenza
3.2.1.2 Rise in demand for rapid diagnostic tests
3.2.1.3 Technological advancements
3.2.1.4 Increase in R&D activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 Variabilities in test sensitivity and specificity
3.2.2.2 Stringent regulatory guidelines
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 GAP analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Influenza Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)
5.1 Key test type trends
5.2 Traditional diagnostic test
5.2.1 Rapid influenza diagnostic test (RIDT)
5.2.2 Direct fluorescent antibody test (DFAT)
5.2.3 Viral culture
5.2.4 Serological assay
5.3 Molecular diagnostic assay
5.3.1 RT-PCR
5.3.2 Loop-mediated isothermal amplification-based Assay (LAMP)
5.3.3 Nucleic acid sequence-based amplification test (NASBAT)
5.3.4 Simple amplification-based assay (SAMBA)
5.3.5 Other molecular diagnostic assays
Chapter 6 Influenza Diagnostic Tests Market Size and Forecast, By End-use (USD Million)
6.1 Key end-use trends
6.2 Hospitals
6.3 Diagnostics centers
6.4 Research laboratories
6.5 Other end-users
Chapter 7 Influenza Diagnostic Tests Market Size and Forecast, By Region (USD Million)
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of MEA
Chapter 8 Company Profiles
8.1 F. Hoffmann-La Roche Ltd
8.2 Abbott
8.3 Becton, Dickinson and Company
8.4 Coris BioConcept
8.5 DiaSorin SpA
8.6 Meridian Bioscience Inc.
8.7 Quidel Corporation
8.8 Sekisui Diagnostics
8.9 Thermo Fischer Scientific Inc.
8.10 Hologic Inc.
